Oral use of specific antibodies for intestinal health
US8052971B2 · kind B2 · utility
3Cited by
23References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 20, 2006 |
| Grant date | Nov 8, 2011 |
| Priority date | — |
| Expiry date | Nov 20, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions are provided to treat enteric disease. The methods and compositions use passive immunity to treat diseases of the gut, including diseases caused by Salmonella sp., E. Coli, Clostridium difficile, Clostridium perfringens A, Clostridium perfringens C, Clostridium perfringens D, canine distemper, feline distemper, Rotavirus, and Parvovirus. Specific antibodies are administered orally to a subject to improve intestinal health.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.